POLONELLI, Luciano
 Distribuzione geografica
Continente #
NA - Nord America 13.282
AS - Asia 11.604
EU - Europa 10.358
SA - Sud America 3.071
AF - Africa 740
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 7
Totale 39.081
Nazione #
US - Stati Uniti d'America 12.771
SG - Singapore 4.632
CN - Cina 3.899
BR - Brasile 2.450
UA - Ucraina 2.119
IE - Irlanda 1.808
DE - Germania 1.631
VN - Vietnam 1.269
SE - Svezia 1.223
FI - Finlandia 1.183
IT - Italia 916
HK - Hong Kong 890
ZA - Sudafrica 553
NL - Olanda 543
CA - Canada 388
RU - Federazione Russa 279
AR - Argentina 265
TR - Turchia 225
GB - Regno Unito 184
AT - Austria 134
EC - Ecuador 126
IN - India 116
FR - Francia 104
BD - Bangladesh 98
IQ - Iraq 89
ID - Indonesia 74
MX - Messico 74
JP - Giappone 56
CO - Colombia 50
PY - Paraguay 49
MA - Marocco 45
BE - Belgio 44
PK - Pakistan 43
PL - Polonia 38
VE - Venezuela 37
CL - Cile 36
KE - Kenya 32
ES - Italia 31
EG - Egitto 27
UZ - Uzbekistan 26
PE - Perù 24
TN - Tunisia 22
AE - Emirati Arabi Uniti 20
UY - Uruguay 20
SA - Arabia Saudita 17
AZ - Azerbaigian 16
IL - Israele 16
EU - Europa 15
NP - Nepal 15
CZ - Repubblica Ceca 14
JO - Giordania 14
BG - Bulgaria 13
KZ - Kazakistan 12
LB - Libano 12
LT - Lituania 12
BO - Bolivia 11
RO - Romania 11
AL - Albania 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
CI - Costa d'Avorio 9
CR - Costa Rica 8
HU - Ungheria 8
RS - Serbia 8
BH - Bahrain 7
BY - Bielorussia 7
NG - Nigeria 6
OM - Oman 6
PA - Panama 6
PS - Palestinian Territory 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
HN - Honduras 5
HR - Croazia 5
KR - Corea 5
LK - Sri Lanka 5
MY - Malesia 5
SY - Repubblica araba siriana 5
AU - Australia 4
BW - Botswana 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
KG - Kirghizistan 4
KW - Kuwait 4
LU - Lussemburgo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
CH - Svizzera 3
EE - Estonia 3
GA - Gabon 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TG - Togo 3
ZW - Zimbabwe 3
CG - Congo 2
Totale 39.039
Città #
Jacksonville 2.243
Singapore 2.028
Dublin 1.806
Chandler 1.158
Ashburn 1.065
Beijing 1.046
Hong Kong 882
Dearborn 780
Nanjing 646
Boardman 585
Santa Clara 583
San Mateo 570
Dallas 537
Johannesburg 511
Ho Chi Minh City 505
Princeton 504
Toronto 320
Des Moines 264
Ann Arbor 245
Bremen 243
Hanoi 238
Moscow 220
Helsinki 216
Wilmington 216
Shenyang 191
São Paulo 190
Izmir 182
Munich 180
Kunming 171
Nanchang 167
Hefei 162
Hebei 160
Los Angeles 158
New York 151
Parma 140
Vienna 125
Shanghai 121
Buffalo 112
Jinan 105
Düsseldorf 103
Grafing 101
Tianjin 90
Changsha 83
Jiaxing 74
Rio de Janeiro 72
Guangzhou 67
Seattle 62
Fremont 61
Brasília 56
Haiphong 54
Quito 52
Woodbridge 52
Marseille 47
Da Nang 46
Houston 45
Curitiba 44
Brussels 42
Turku 42
Columbus 40
Porto Alegre 38
Norwalk 36
Milan 35
Biên Hòa 34
Belo Horizonte 33
Salvador 33
Brooklyn 32
Hangzhou 31
Tokyo 31
Baghdad 28
Guayaquil 28
Hải Dương 28
Nairobi 27
Rome 27
Zhengzhou 27
Council Bluffs 26
Warsaw 26
Campinas 25
Chennai 24
San Francisco 24
Thái Bình 24
Chicago 23
London 23
Borås 22
Buenos Aires 22
Frankfurt am Main 22
Manaus 22
Tashkent 22
Chengdu 21
Bắc Ninh 20
Fortaleza 20
Jakarta 20
Montreal 20
Redondo Beach 20
The Dalles 20
Wuhan 20
Asunción 19
Atlanta 19
Caxias do Sul 19
Osasco 19
Recife 19
Totale 21.988
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 252
Il problema dell’antibiogramma nelle infezioni da funghi filamentosi. 184
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 177
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 176
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 167
Antibiocorpi: Anticorpi anti-idiotipo ad attività antibiotica in vivo ed in vitro 163
Antibodies as a source of anti-infective peptides: an update 161
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 156
Micologia Clinica. Manuale di Laboratorio. 154
L’antibiogramma per i miceti 151
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 149
Antifungal peptides within the antibodies 148
A synthetic peptide as a novel anticryptococcal agent 147
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 145
Caratterizzazione ed isotipizzazione di anticorpi monoclonali murini anti-laminarina con potenziale attività candidacida. 145
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 144
Fungicidal activity of peptides encoded by immunoglobulin genes 143
Metabolic profiling of Candida albicans 143
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 141
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 140
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 139
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 137
Antifungal activity of the C-terminal peptide from human serum albumin 133
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 133
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 132
Anaerobic yeast killer system. 131
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 130
Antibody peptide based antifungal immunotherapy 129
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 129
Peptides from the inside of the antibodies are active against infectious agents and tumours 129
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 128
Antibiocorpi: anticorpi anti-idiotipo ad attività antibiotica 127
Antibody-mediated protective immunity in fungal infections 127
Natural and synthetic peptides with antifungal activity 127
Oral and maxillofacial fungal infections 127
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 126
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 125
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 124
Conformation-sensitive Antibodies against Alzheimer Amyloid-beta by Immunization with a Thioredoxin-constrained B-cell Epitope Peptide 122
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 122
AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model 120
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 120
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 119
Anticorpi immagini interne di tossine killer 119
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 118
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 118
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 117
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 115
A Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species 115
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 115
Activity of nitroimidazole derivative synthetic compounds on Trichomonas vaginalis and Candida albicans isolates 113
Antireceptor yeast killer toxin-like antibiobodies 113
Antibiobodies: antibiotic-like antiidiotypic antibodies. 113
A case of disseminated fatal infection caused by Nocardia caviae. 111
A multicenter study of the in vitro activity of voriconazole against 1,996 yeast and 192 mould clinical isolates 111
Antibiobodies: antibiotic internal image antibodies 111
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 111
Cases of imported malaria in Parma observed in the period January-September 1994 110
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 110
Caratterizzazione dell'epitopo polisaccaridico reattivo con IgA secretorie della mannoproteina maggiore da stress secreta da Candida albicans. 110
Chimeric symbionts expressing a Wolbachia protein stimulate mosquito immunity and inhibit filarial parasite development 110
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 109
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 109
A microautomated dilution method for susceptibility testing with antifungal drugs. 109
Valutazione del sistema Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 per il rilevamento di micobatteri dai materiali patologici in comparazione ai metodi radiometrico e tradizionale 109
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 109
Innate antimicrobial and antiviral activities of antibody peptides 108
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 108
Mode of action of a killer peptide against Toxoplasma gondii 107
Anti-idiotypic vaccination against group B streptococci 106
In vitro and in vivo anticandidal activity of killer peptide derivatives 106
Involvement of beta-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin 104
Actinomiceti. 104
Metabolic profile of Candida albicans 102
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 102
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 101
Antibodies as Crypts of Antiinfective and Antitumor Peptides 100
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo 100
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 99
Marcatori epidemiologici. 99
In vitro tests: how do they influence therapeutic choices? 98
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 98
Caratterizzazione antigenica di Microsporum canis, M. distortum, M. ferrugineum e Trichophyton soudanense. 97
Restriction of Influenza virus multiplication induced by PK peptide treatment 97
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 96
Antibiotic antibodies 96
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 96
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 95
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 95
Immagine interna del fenomeno killer dei lieviti 94
A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi 94
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 94
A novel glyco-conjugate vaccine against fungal pathogens 93
Biotipizzazione di microorganismi patogeni mediante il sistema killer dei lieviti. 93
Yeast killer toxins and dimorphism. 93
Any antibody fragment might exert antifungal activity 93
Identificazione di lieviti produttori di tossine killer in vivo 92
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 92
Protective antifungal yeast killer toxin-like antibodies 91
Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans 91
Totale 12.041
Categoria #
all - tutte 140.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.651 0 0 0 0 0 32 456 19 581 40 502 21
2021/20222.384 23 6 7 50 83 111 333 458 97 285 95 836
2022/20235.790 940 414 267 308 585 607 48 289 2.149 20 111 52
2023/20241.866 105 189 65 53 189 511 50 100 20 133 167 284
2024/20256.781 43 565 563 307 587 571 107 210 1.281 855 464 1.228
2025/20269.892 1.128 1.804 2.195 2.316 2.308 141 0 0 0 0 0 0
Totale 39.243